Trending

MRI imaging

FDA clears Bayer’s Gadavist as first contrast agent for cardiac MRI

FDA clears Bayer’s Gadavist as first contrast agent for cardiac MRI

Bayer’s Gadavist has become the first imaging agent approved in the US to detect blockages in the hearts

X

FDA clears Bayer’s Gadavist as first contrast agent for cardiac MRI

https://pharmaphorum.com/news/fda-clears-bayers-gadavist-as-first-contrast-agent-for-cardiac-mri/

Digital Health Round-up – Siemens and Biogen take on MS imaging

Digital Health Round-up – Siemens and Biogen take on MS imaging

A round-up of this week’s digital healthcare news. Marco Ricci reports.

X

Digital Health Round-up – Siemens and Biogen take on MS imaging

https://pharmaphorum.com/views-and-analysis/digital-health-round-siemens-biogen-take-ms-imaging/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com